The Move Home Ch. 01

Prologue:
This is my 14th erotic story and Literotica submission. I am always indebted to Candy_Kane54 (CK) for her continuing commitment to helping me improve my writing style. CK has provided 100 percent of the editing and style advice for all 14 stories. I am so grateful since I would have never written these stories without CK's enthusiastic and continuing support.
My Lesbian Romance stories focus on the trials and lives of strong and powerful women. Romance, not sex, is the driving factor in these stories, which are 100 percent Fiction; however, many are based on real-life experiences of friends or acquaintances.
Most stories are lesbian love and romance heavy with children present. As a general rule, no sexual activity occurs while children are present in the home. Maintaining this rule requires that relatives and friends share active roles in the stories, allowing the little ones a fun place to visit when the sex heats up at home.
The Move Home is somewhat of a variation on my usual themes since there is a significant Male/Female Non-Sexual romance component. Renee Mia Evans and Jules Alan Evans are siblings reared by wonderful parents in a close-knit family setting.
Jules is two years older and was always protective of Renee during their youth into early adulthood. They were physically separated for the first time when Renee accepted a six-month internship at a major Pharmaceutical Firm based in NJ. Renee was in her senior year at the University of North Carolina Charlotte (UNCC). Her internship commenced immediately following graduation. Two months into her six-month internship, Renee was offered a plum job in the CEO's Headquarters Office and remains there four years later as a Special Research Associate (SRA).
Jules had taken an entry-level technician job at a local Research and Clinical Trial Center right out of High School. He currently holds a senior position at the company, having worked there for ten years. While working full-time, Jules attended night and online studies at UNCC, earning an MA in Chemical Engineering.
In The Move Home, Jules and Renee have the opportunity of working together developing products for COVID Therapy. Renee returns home to Charlotte, NC, and successfully guides her new division for their US-FDA facility license. She unexpectedly embraces Lesbian Love in Charlotte after eight years of studying and working tirelessly toward her long-range career goals.
Jules has remained at Catawba Research in Charlotte, becoming a Senior Executive at the research firm. Jules now also finds love after meeting his female soul-mate a year before Renee moved home. Jules and his soul-mate are romantically featured in PT. 01, however, without any explicit sex.
All explicit sexual activities in this story are lesbian, with young ladies aged-23 or older. Like my other stories, THE MOVE HOME builds slowly with lots of personal and business background detail before there is any sexual activity. Most explicit sex scenes feature a dominant but absolutely loving woman as the definite TOP controlling the action.
If this is your type of Lesbian Romance-Love-Sex Story... ENJOY!
INVITATION:
Renee Mia Evans was thoughtfully sitting in on the Board of Directors meeting of her company, BMS-C, at Chairman Boyle's request. The board was in final discussions before deciding whether to start a spinoff division from their Cancer Specialty products. There was considerable internal pressure for BMS-C to develop a full line of Coronavirus (COVID) Therapeutic Products. The company would be late entering the anti-viral therapeutics market. However, some of the more aggressive junior execs felt BMS-C could quickly close the gap.
Most knowledgeable scientific experts fully agreed that COVID-type viruses would be a fixture worldwide for the near future. There had been several SARS/MERS outbreaks in the past 20-years, and an endless stream of DNA mutations appeared to be on the horizon for the next one or two decades.
These ambitious junior exec types were all battling for corporate recognition, relevance, and future program directors roles. Virtually 100% of their primary arguments revolved around BMS-C's worldwide leadership experience in Cancer Therapeutics. To them, it seemed automatic that being a major player in Cancer Therapy offered the company a golden opportunity to become dominant in COVID therapeutics within one or two years.
The current CEO and Board Chairman, Jackson Alan Boyle, was not confident that entering the SARS/MERS/C-19 coronavirus therapeutics market was a wise deviation for BMS-C. Yes, the company was well established in cancer therapeutics expertise, which was the driving force behind their Multi-Billion $USD annual sales record. However, anti-viral therapy was not a genetically identical twin to cancer therapy.
Chairman Boyle had been the dominant force in BMS-C's ascendency to the worldwide leader in ankara yabancı escort cancer therapeutic product development. Now well into his 12th year as CEO and Chairman of the Board (COB), he certainly was open to further in-depth discussions on this potential new high sales $USD product area. But he really questioned his young tigers' theory that success with this project would be a walk in the park.
Chairman Boyle specifically invited Renee to this meeting as she was his SRA, focusing on new product development and expansion opportunities. However, Renee was decidedly baffled at the why of her invitation to this high-level meeting. Her usual routine was to provide the Chairman, Judy Walker, and Directors with an in-depth, well-written report highlighting any and all cautions or reservations regarding a specific product area expansion.
At twenty-six years old, Renee was unquestionably the least powerful person in attendance, so she avidly read the faces of each speaker's pitch. Renee did not care whether they were PRO or CON, as she was utterly focused on evaluating the confidence levels of their various presentations.
Renee also continued having concerns about why Chairman Boyle had sought her official presence at this high-level meeting. She felt a bit inadequate with being in this plush boardroom with several attendees earning 5X her income. So Renee was desperately trying to appear nonchalant as if her presence was more than an occasional occurrence for such high-powered meetings.
There were the inevitable questionable looks at her presence from several higher-level junior executives. Most of them hoped to advance upward to the corporate inner circle based on this potential blockbuster product line. For this reason, each young exec sought to assess or determine Renee's threat level to their ambitions.
Actually, most of the attendees were personally unaware of Renee's existence, which was fine with her. All official attendees knew Renee's name since she had authored several critical reports for the Chairman during her four-year tenure. Too many of them, however, Renee was considered just a glorified paper pusher.
The one undeniable fact was Renee adored Chairman Boyle and his Executive Associate (EA), Ms. Judy Walker. On paper, Renee reported independently to the Chairman. In actuality, she worked closely with Judy Walker, who fully respected her.

After receiving the Chairman's summons to attend this meeting, Renee spent the next three days researching COVID Therapy. She wanted to attain a complete understanding of every possible aspect and outcome of the COVID Therapy Project. Renee was keenly aware that any misstep on this project could adversely affect BMS-C's sterling reputation in the Cancer Therapy R